Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. Net Income 2015–2025
Seres Therapeutics, Inc. annual/quarterly net income history and growth rate from 2015 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Seres Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -19.9 M, a 160.93% decrease year-over-year.
- Seres Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was 109.7 M, a 247.70% decrease year-over-year.
- Seres Therapeutics, Inc. annual net income for 2025 was 5.7 M, a 4088.24% increase from 2024.
- Seres Therapeutics, Inc. annual net income for 2024 was 136000, a 100.12% decrease from 2023.
- Seres Therapeutics, Inc. annual net income for 2023 was -113.7 M, a 54.54% decrease from 2022.
- Seres Therapeutics, Inc. annual net income for 2022 was -250.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Seres Therapeutics, Inc. Net Income — FAQ
Seres Therapeutics, Inc. (MCRB) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Seres Therapeutics, Inc.'s net income?
Seres Therapeutics, Inc. (MCRB) reported net income of $6M for fiscal 2025.
Where can I see MCRB's net income history?
The chart and table above show Seres Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.